Cited by 198Asthma and respiratory diseasesIL-33, ST2, and ILC PathwaysAllergic Rhinitis and Sensitization

Cytokines and growth factors in airway remodeling in asthma

Doherty, Taylor, Broide, David·2007·Current Opinion in Immunology

Abstract

Airway remodeling in asthma is defined by several structural changes including epithelial cell mucus metaplasia, an increase in peribronchial smooth muscle mass, subepithelial fibrosis, and angiogenesis. Cytokines, chemokines, and growth factors released from inflammatory and structural cells in the airway are considered to play a pivotal role in the development of remodeling. Studies of allergen induced airway remodeling in transgenic mice suggest an important role for TGF-beta, VEGF, Th2 cytokines (IL-5, IL-9, IL-13), and epithelial derived NF-kappaB regulated chemokines in airway remodeling. Although studies of bronchial biopsies from human asthmatics also demonstrate expression of TGF-beta, VEGF, IL-5, IL-9, IL-13, and NF-kappaB regulated chemokines, further human intervention studies are required in which individual cytokines or chemokines are neutralized to define their role in airway remodeling.

Integrity signals

Registry

Crossref · 10.1016/j.coi.2007.07.017

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Doherty, T., & Broide, D.
Affiliations
University of California San Diego (US)
Corresponding author
  • Doherty, Taylor
  • Broide, David
Venue
Current Opinion in Immunology
Publisher
Elsevier BV
Published
2007-12
Volume
19
Issue
6
Pages
676-680
ISSN
0952-7915 (ISSN-L)
OpenAlex
W1983403805
Cited by
198
References
32
Citations by year
2026: 2 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 8 · 2020: 10 · 2019: 7 · 2018: 8 · 2017: 14 · 2016: 6 · 2015: 11 · 2014: 12 · 2013: 11 · 2012: 13
FWCI
1.54
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R37AI038425, R01AI072115, U19AI070535)
Topics
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
Keywords
airway remodeling, asthma, cytokines, growth factors, chemokines, TGF-beta, vascular endothelial growth factor, IL-5, IL-9, IL-13, Th2 cytokines, NF-κB, mucus metaplasia, subepithelial fibrosis, angiogenesis, transgenic mouse model
MeSH terms
Animals, Asthma, Eosinophils, Humans, Interleukins, CD4-Positive T-Lymphocytes, Transforming Growth Factor beta, Th2 Cells, Chemokines, Vascular Endothelial Growth Factor A, Metalloproteases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review